Skip to main content

Table 5 Comparison of physician-reported outcome after RT and PRO (n = 38). In both groups, only new and worsened symptoms after RT are listed

From: Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)

CTCAE grade

Physician-reported after RT

PRO

1/2

3

4

1/2

3

4

Pain

9 (24%)

–

–

16 (42%)

–

–

Fatigue

10 (26%)

–

–

25 (66%)

–

–

Nausea/vomiting

1

–

–

4 (11%)

–

–

Dermatitis

1 (3%)

–

–

4 (11%)

1 (3%)

–

Hyperpigmentation

2 (5%)

–

–

2 (5%)

–

–

Edema

4 (11%)

–

–

14 (37%)

–

–

Osteonecrosis, rib fracture

–

–

–

–

–

–

Sensory deficits

–

–

–

15 (39%)

1 (3%)

1 (3%)

Motor deficits

–

–

–

13 (34%)

2 (5%)

 

Weight loss

4 (11%)

–

–

9 (24%)

1 (3%)

–

Fibrosis

17 (45%)

–

–

–

–

–

Pneumonitis

10 (26%)

–

–

–

–

–

Dysphagia

2 (5%)

–

–

14 (37%)

1 (3%)

–

Dyspnea

16 (42%)

–

–

18 (47%)

4 (11%)

2 (5%)

Cough

14 (37%)

–

–

24 (63%)

1 (3%)

–

Xerostomia

1 (3%)

–

–

22 (58%)

–

–

Dysphonia

–

–

–

12 (32%)

1 (3%)

–

  1. RT Radiotherapy, PRO Patient-reported outcome, CTCAE Common Terminology Criteria for Adverse Events